NOW AVAILABLE
The next generation in online publishing...

Sign up to read the digital versions of Managed Care, P&T, and Biotechnology Healthcare. These digital editions are free, searchable, and can be downloaded and read offline. To read a sample of the digital version of Managed Care, follow this link:

Sample digital edition

Register for a free digital subscription

Archive issues of Managed Care:

• January 2008
• February 2008
• March 2008
• April 2008
• May 2008
• June 2008
• July 2008
• August 2008

MANAGED CARE May 2004. ©MediMedia USA

NEWS AND COMMENTARY

Biologics among fastest growers

The U.S. pharmaceutical market was $211 billion in 2003, the first time the market exceeded $200 billion. Roughly $22 billion of that market was biotech products, according to IMS Health. The strongest growth was seen in the generic and biologic sectors. Managed care plans and pharmacy benefit managers can benefit from the strong generic presence in the market, but also face challenges relating to biotech drugs.

Dollar growth in sales

September 2002–September 2003

SOURCE: RETAIL AND PROVIDER PERSPECTIVE, IMS HEALTH, PLYMOUTH MEETING, PA, 2003